Chronic urticaria: Assessment and treatment

Australian Family Physician

Volumn 39, Issue 3, 2010, Pages 135-138

  Fernando, Suran ^a   Broadfoot, Andrew ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Allergy and immunology; Skin diseases; Urticaria

Indexed keywords

HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST;

ARTICLE; CHRONIC DISEASE; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; PATHOPHYSIOLOGY; RISK FACTOR; URTICARIA;

CHRONIC DISEASE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HISTAMINE H2 ANTAGONISTS; HUMANS; RISK FACTORS; URTICARIA; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 77954645725     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 1969;81:588-97.
2. Sibbald RG, Cheema AS, Lozinski A, Tarlo S. Chronic urticaria. Evaluation of the role of physical, immunologic, and other contributory factors. Int J Dermatol 1991;30:381-6.
3. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004;114:465-74
4. Kirby JD, Matthews CN, James J, Duncan EH, Warin RP. The incidence and other aspects of factitious wealing (dermographism). Br J Dermatol 1971;85:331-5.
5. Fernando SL. Cold-induced anaphylaxis. J Pediatr 2009;154:148-148.e1.
6. Khan DA. Chronic urticaria: diagnosis and management. Allergy Asthma Proc 2008;29:439-46.
7. Mehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992;26:441-8.
8. Verneuil L, Leconte C, Ballet JJ, et al. Association between chronic urticaria and thyroid autoim-munity: a prospective study involving 99 patients. Dermatology 2004;208:98-103.
9. Mortureux P, Leaute-Labreze C, Legrain-Lifermann V, Lamireau T, Sarlangue J, Taieb A. Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol 1998;134:319-23.
10. Poole JA, Rosenwasser LJ. Chronic idiopathic urti-caria exacerbated with progesterone therapy treated with novel desensitization protocol. J Allergy Clin Immunol 2004;114:456-7.
11. Boguniewicz M. The autoimmune nature of chronic urticaria. Allergy Asthma Proc 2008;29:433-8.
12. Zuberbier T, Bindslev-Jensen C, Canonica W, et al. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy 2006;61:321-31.
13. Gilbert C, Mazzotta P, Loebstein R, Koren G. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf 2005;28:707-19.
14. Smith PF, Corelli RL. Doxepin in the management of pruritus associated with allergic cutaneous reactions. Ann Pharmacother 1997;31:633-5.
15. Rumbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995;96:901-5.
16. Aversano M, Calazzo P, Iorio G, Ponticiello L, Lagana B, Leccese F. Improvement of chronic idiopathic urticaria with L-thyroxine: a new TSH role in immune response? Allergy 2005;60:489-93.